Veracyte SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 4, 2026, 4:08 p.m. ETView on SEC.gov
Results of operations and financial condition · Other events · Financial statements and exhibits
AI summary, unreviewedVeracyte Q3 2026 Revenue $151.8 Million (+15%) and Non-GAAP EPS $0.51 Beat Consensus; Narrows 2026 Revenue Guidance to $590-$593 Million and Announces $100 Million Buyback
8-KSept. 14, 2026, 4:07 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Completion of acquisition or disposition of assets · Regulation FD disclosure · Financial statements and exhibits
8-KJuly 30, 2026, 4:18 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits